← Back

DataRobot · Partnership

BCG Joint Solution Motion

$500K revenue · $2M pipeline generated
Situation

DataRobot had strong platform capability but limited access to the enterprise AI transformation conversations that start at the strategy level — the conversations where budgets get shaped and platforms get selected. BCG had exactly that access: the client relationships, the transformation credibility, and the mandate to recommend technology.

BCG's value to clients, though, rested on being vendor-neutral — recommending whatever technology fit the engagement, not steering clients toward a partner's platform. That made a formal partnership something BCG's leadership approached cautiously: any structure had to give their teams a capable platform to build on without compromising the independence their advisory business depended on.

Approach

To resolve that tension, I designed a pass-through licensing model: BCG licensed DataRobot's platform for use in client engagements rather than reselling it as a recommended vendor, giving case teams a technology they could deploy freely without putting BCG's neutrality on the line or committing them to DataRobot exclusivity.

To prove the model, I worked with BCG's life sciences practice to identify pharmacovigilance as the first joint solution and piloted it with an initial client. In parallel, I designed and ran a 400-person DataRobot platform training program for BCG data scientists, building the capability for their teams to build and deploy independently without requiring DataRobot involvement in every engagement.

Impact
$2M+
pipeline generated, with $500K in early revenue

The training program and licensing structure gave BCG's practice a repeatable way to build AI into engagements without waiting on DataRobot for every deal. Case teams could scope, price, and deliver joint engagements independently, and a pipeline review cadence and internal advocacy network kept new opportunities surfacing across practices.


Commercial

The first joint solution, a pharma pharmacovigilance product, was developed and sold to an initial client, validating the model. That engagement established the repeatable commercial motion: a defined client engagement approach, the pass-through licensing structure, and inclusion in BCG onboarding training for new data scientists.